Kevin R Flaherty

 Kevin Flaherty
Professor of Internal Medicine
IRB Vice Chair and Associate Residency Program Director
Medical School
Email:
[email protected]
Available to mentor
Kevin R Flaherty
Kevin Flaherty
Professor
  • Recent Publications

  • Manage Your Profile

    • Recent Publications

     See All Publications
    • Journal Article
      Workplace Productivity Loss in Patients with Progressive Pulmonary Fibrosis: Data from the ILD-PRO Registry
      Shetty S, Swaminathan AC, Li P, Neely ML, Olson AL, Snyder LD, Whelan TPM, Walia R, Veeraraghavan S, Strek ME, Southern B, Liu G, Safdar Z, Russell T, Rosas I, Roman J, Ramaswamy M, Raj R, Porteous M, Paul T, Namen A, Morrison L, Maher TM, Mageto Y, Luckhardt TR, Lobo L, Lipchik R, Pinto-Plata V, Sanchez H, Lasky JA, Hewlett J, Gupta E, Kim HJ, Kebbe J, Kaner RJ, Hotchkin D, Hamblin M, Case AH, Gupta N, Gulati M, Fowler R, Flaherty KR, Fitzgerald J, Bemiss B, Dilling D, Condos R, Chardon D, Belperio JA, Beegle S, Bandyopadhyay D, Baker A. Lung, 2026 Dec 1; 204 (1): DOI:10.1007/s00408-026-00895-x
      PMID: 42201372
    • Journal Article
      Metabolomic profiling reveals distinct and shared biology in COPD and IPF
      Rosario A, Prince N, Madha-Krause S, Lutz SM, Hecker JE, Yun JH, Cho MH, Halu A, Washko GR, Sciurba FC, Barwick L, Limper AH, Flaherty KR, Criner GJ, Brown KK, Wise R, Martinez FJ, Bowler RP, Gerszten RE, Clish CB, Silverman EK, Kelly RS. Metabolomics, 2026 Oct 1; 22 (5): DOI:10.1007/s11306-026-02508-3
      PMID: 42631875
    • Journal Article
      Survival According to Radiomic and Visual UIP Classification in Fibrotic ILD.
      Wang JM, Pugashetti JV, Thompson J, Kang E, Kazerooni EA, Flaherty KR, Belloli EA, Sheth JS, O'Dwyer DN, Han MK, Hatt CR, Oldham JM, Chung JH. Chest, 2026 Aug 12; DOI:10.1016/j.chest.2026.08.002
      PMID: 42586496
    • Journal Article
      Progressive pulmonary fibrosis: a state-of-the-art review.
      Cottin V, Brown K, Flaherty KR, Kolb M, Lynch DA, Oldham J, Valenzuela C, Wijsenbeek M, Wells AU. Eur Respir J, 2026 Jun 11; DOI:10.1183/13993003.01557-2025
      PMID: 42276742
    • Journal Article
      A82-01 TETON-1 Phase 3 Clinical Trial Of Inhaled Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
      Nathan SD, Behr J, Cottin V, Smith PM, Deng C, Rao Y, Breytenbach N, Bell H, Peterson L, Flaherty KR. American Journal of Respiratory and Critical Care Medicine, 2026 Jun 24; 212 (Supplement_2): aamag286.007 DOI:10.1093/ajrccm/aamag286.007
    • Journal Article
      B95-09 TETON Phase 3 Clinical Trials of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis: Integrated Efficacy and Safety Results for TETON-1 and TETON-2
      Nathan SD, Behr J, Cottin V, Smith PM, Deng C, Rao Y, Breytenbach N, Bell H, Peterson L, Flaherty KR. American Journal of Respiratory and Critical Care Medicine, 2026 Jun 24; 212 (Supplement_2): aamag286.180 DOI:10.1093/ajrccm/aamag286.180
    • Journal Article
      C103-25 TETON-1 Phase 3 Clinical Trial of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
      Nathan SD, Behr J, Cottin V, Smith PM, Deng C, Rao Y, Breytenbach N, Bell H, Peterson L, Flaherty KR. American Journal of Respiratory and Critical Care Medicine, 2026 Jun 24; 212 (Supplement_2): aamag286.189 DOI:10.1093/ajrccm/aamag286.189
    • Journal Article
      Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.
      Nathan SD, Smith P, Deng C, King CS, De Salvo M, Weigt SS, Pandya S, Bandyopadhyay D, Lasky JA, Krishna R, Hambly N, Ramaswamy M, Kebbe J, Ettinger N, Gao J, Rao Y, Breytenbach N, Peterson L, Bell H, Behr J, Cottin V, Flaherty KR, TETON-1 Trial Investigators . N Engl J Med, 2026 May 18; DOI:10.1056/NEJMoa2501488
      PMID: 42149993